On Friday, doctors at Massachusetts General Hospital announced that a 66-year-old New Hampshire man had successfully received ...

The second person ever has received a transplant with a genetically modified pig kidney.

The surgery comes at a turning point in the quest to tell if animal-to-human transplants could help ease the shortage of ...

The recipient was Tim Andrews, a 66-year-old New Hampshire resident who had end-stage kidney disease and was on dialysis for ...

Doctors at Massachusetts General Hospital transplanted a pig kidney into a 66-year-old patient with end-stage kidney disease.

The FDA will allow two biotechnology companies to run clinical trials: United Therapeutics and eGenesis. United Therapeutics ...

The research offers hope to tens of thousands of patients with kidney failure who are on a long waiting list for an organ ...

The first clinical trials using organs from genetically modified pigs offer hope to patients with kidney failure, who face a ...

Doctors at Massachusetts General Hospital have transplanted a pig kidney to a 66-year-old patient with end-stage kidney ...

For the second time in less than a year, doctors at Massachusetts General Hospital have transplanted a genetically-edited pig ...

Tim Andrews, 66, was diagnosed with end-stage kidney disease more than two years ago. Since then, he's treated his condition ...

The small trial will help to establish whether kidneys from genetically modified pigs can be transplanted into people safely and effectively.